Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
The Precision Hypertension Care Study
NCT02774460Phase 4Completed
- Sponsor
- Uppsala University
- Start
- Feb 2017
- Primary completion
- Jun 2021
- Modality
- Prodrugs/Conditional Activator Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of lisinopril, candesartan, amlodipine, hydrochlorothiazide in hypertension (HTN), sponsored by Uppsala University. Started Feb 2017; status: completed.
02
Drugs
lisinoprilcandesartanamlodipinehydrochlorothiazide
03
Conditions
hypertension (HTN)
Beyond the preview
Go deeper on NCT02774460.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02774460.